Total Payments
$12,863
2024 Payments
$1,528
Companies
81
Transactions
689
Medicare Patients
13,265
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$11,469 (89.2%)
Travel$1,072 (8.3%)
Education$322.93 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,469 | 676 | 89.2% |
| Travel and Lodging | $1,072 | 4 | 8.3% |
| Education | $322.93 | 9 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,461 | 105 | $0 (2024) |
| Inspire Medical Systems, Inc. | $1,228 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,014 | 34 | $0 (2024) |
| Genentech USA, Inc. | $916.44 | 66 | $0 (2024) |
| Grifols USA, LLC | $822.29 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $679.41 | 38 | $0 (2024) |
| Insmed, Inc. | $613.81 | 25 | $0 (2024) |
| Amgen Inc. | $576.61 | 36 | $0 (2024) |
| GENZYME CORPORATION | $410.21 | 21 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $358.90 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,528 | 73 | AstraZeneca Pharmaceuticals LP ($211.05) |
| 2023 | $2,836 | 88 | Inspire Medical Systems, Inc. ($1,207) |
| 2022 | $1,492 | 85 | Insmed, Inc. ($217.81) |
| 2021 | $1,648 | 92 | GlaxoSmithKline, LLC. ($340.89) |
| 2020 | $1,232 | 75 | GlaxoSmithKline, LLC. ($330.05) |
| 2019 | $1,706 | 99 | Genentech USA, Inc. ($294.37) |
| 2018 | $1,139 | 87 | Amgen Inc. ($126.48) |
| 2017 | $1,281 | 90 | Amgen Inc. ($153.11) |
All Payment Transactions
689 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.03 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/02/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: Medical Device | ||||||
| 11/20/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.15 | General |
| 11/13/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $57.48 | General |
| Category: Immunology | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $24.10 | General |
| Category: Narcoplepsy | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.40 | General |
| 10/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Pulmonology | ||||||
| 10/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $84.38 | General |
| Category: Endo-Mechanical | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: COVID-19 | ||||||
| 10/08/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/04/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: NEUROLOGY | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 3,023 | 3,648 | $1.0M | $320,843 |
| 2022 | 33 | 3,320 | 4,041 | $1.1M | $345,105 |
| 2021 | 31 | 3,576 | 4,582 | $1.2M | $394,078 |
| 2020 | 32 | 3,346 | 4,309 | $1.2M | $368,473 |
Total Patients
13,265
Total Services
16,580
Medicare Billing
$1.4M
Procedure Codes
139
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 176 | 178 | $268,780 | $78,377 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 575 | 897 | $219,475 | $76,508 | 34.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 117 | 120 | $204,000 | $55,891 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 118 | 118 | $37,090 | $13,596 | 36.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 280 | 331 | $33,100 | $12,630 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 66 | $22,710 | $8,728 | 38.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 342 | 450 | $34,200 | $8,066 | 23.6% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 227 | 298 | $25,330 | $7,834 | 30.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 172 | 172 | $17,200 | $6,502 | 37.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $13,030 | $5,141 | 39.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 75 | $9,750 | $4,481 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 77 | $13,175 | $4,456 | 33.8% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 30 | 30 | $7,680 | $4,290 | 55.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 32 | 33 | $7,590 | $4,240 | 55.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 54 | 54 | $4,560 | $3,881 | 85.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $10,939 | $3,848 | 35.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 38 | $9,310 | $3,663 | 39.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 18 | $16,254 | $2,917 | 17.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 62 | 63 | $4,095 | $2,451 | 59.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 26 | $5,026 | $2,340 | 46.5% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 81 | 86 | $6,450 | $2,047 | 31.7% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 16 | 16 | $12,800 | $1,710 | 13.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 58 | 58 | $2,308 | $1,692 | 73.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 55 | 55 | $7,150 | $1,404 | 19.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 13 | 13 | $5,200 | $896.87 | 17.2% |
About Dr. David Maybee, MD
Dr. David Maybee, MD is a Critical Care Medicine healthcare provider based in New Bern, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245286467.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Maybee, MD has received a total of $12,863 in payments from pharmaceutical and medical device companies, with $1,528 received in 2024. These payments were reported across 689 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($11,469).
As a Medicare-enrolled provider, Maybee has provided services to 13,265 Medicare beneficiaries, totaling 16,580 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Sleep Medicine
- Location New Bern, NC
- Active Since 05/26/2006
- Last Updated 03/25/2014
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1245286467
Products in Payments
- INSPIRE (Device) $1,228
- Xolair (Biological) $828.48
- Arikayce (Drug) $597.57
- DUPIXENT (Biological) $561.66
- NUCALA (Biological) $558.43
- TRELEGY ELLIPTA (Drug) $549.57
- Prolastin-C Liquid (Biological) $523.12
- OFEV (Drug) $447.49
- BREZTRI (Drug) $329.68
- OPSUMIT (Drug) $279.91
- ACTHAR (Biological) $204.57
- AIRSUPRA (Drug) $190.64
- Prolia (Biological) $176.86
- Prolastin-C (Biological) $173.81
- VYEPTI (Biological) $171.26
- TEZSPIRE (Biological) $168.57
- TEGSEDI (Drug) $143.75
- XOLAIR (Biological) $141.00
- XARELTO (Drug) $137.52
- REMICADE (Biological) $134.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.